PHILIP FERNEAU

Profile

First Name

: PHILIP

Middle Name

:

Last Name

: FERNEAU

Related Companies
Titles
Company Name
Related People
DIRECTOR
FETCH ENTERPRISES INC
WILLIAM END, EDWARD HOWELL, DAVID SHAW, TODD WARDEN
DIRECTOR
DIRECT VET MARKETING, INC.
BETSY ATKINS, PAUL BERGKAMP, KEVIN BITTERMAN, EDWARD CAHILL, SEAN CARNEY, YUMIN CHOI, PHILIP J. FERNEAU, SARA KIM, SARAH KIM, TERRENCE MCGUIRE, EDWARD MCNAMARA, KERRY MUSE, RAVI SACHDEV, RAVI SADCHEV, BENJAMIN SHAW, BENJAMIN J. SHAW, DAVID SHAW, DAVID E. SHAW
DIRECTOR
AVITIDE, INC.
ERRIK ANDERSON, TILLMAN GERNGROSS, COLIN GREENSPON, RISHI GUPTA, KEVIN ISETT, KEVIN ISSETT, SCOTT KENNEDY, WARREN KETT, CLAUDIO NESSI, IAN RATCLIFFE, MICHAEL ROSS, AJAY ROYAN, JON SHELLER, JONATHAN SHELLER
DIRECTOR
COMPASS THERAPEUTICS LLC
ERRIK ANDERSON, TIMOTHY ANDERSON, BEN AUSPITZ, DAMON BANKS, VERED BISKER-LEIB, PIOTR BOBROWICZ, WILL EDEN, CARL GORDON, JEB LEDELL, SARA MANNLE, THOMAS SCHUETZ, THOMAS J SCHUETZ, THOMAS J. SCHUETZ, JONATHAN SHELLER, STEPHEN SQUINTO, STEVEN SQUINTO, BRUCE STEEL, SCHUETZ THOMAS, STEVE TREGAY
EXECUTIVE OFFICER
VOX HEALTH FUND, LP
N/A BOREALIS CAPITAL PARTNERS IV, LLC
DIRECTOR
COMPASS THERAPEUTICS, INC.
VERED BISKER-LEIB, CARL L. GORDON, THOMAS J. SCHUETZ, STEPHEN P. SQUINTO, JULIE SUNDERLAND
DIRECTOR
ANKYRA THERAPEUTICS, INC.
TILLMAN GERNGROSS, TERRANCE MCGUIRE, AJAY ROYAN
DIRECTOR
AMAGMA, INC.
JEAN-FRANCOIS FORMELA, TILLMAN GERNGROSS, TILLMAN U. GERNGROSS, VISHAL PATEL, AMY SCHULMAN
EXECUTIVE OFFICER
BOREALIS FUND V - VETERINARY INNOVATION, LP
N/A BOREALIS CAPITAL PARTNERS V, LLC, BENJAMIN SHAW, JULIA STEPHANUS
EXECUTIVE OFFICER
BOREALIS FUND VI, LP
N/A BOREALIS CAPITAL PARTNERS VI, LLC, BENJAMIN SHAW
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-05-04
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-05-05 
2022-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-12 
2022-09-20
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2021-10-06 
2022-06-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-23 
2021-09-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-26 
2020-07-01
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-06-17 
2020-07-01
D
Link
OTHER 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-06-19 
2020-01-27
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2017-09-01 
2019-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-15 
2018-08-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-09 
2018-08-07
D/A
Link
PRIVATE EQUITY FUND 
 
NOT APPLICABLE 
 
2017-09-01 
2018-07-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-17 
2018-01-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2017-12-22 
2018-01-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-18 
2017-06-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-13 
2016-09-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-17 
2015-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-23 
2015-07-17
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-02 
2015-07-16
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-02 
2015-07-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-17 
2015-03-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-10 
2014-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-27 
2013-06-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-04 
2013-03-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-04 
2012-06-12
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-17 
2011-05-20
D/A
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-11 
2010-07-01
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-11 
2010-07-01
D
Link
RETAILING 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-24